Fig. 2: Change in HbA1c from baseline to Week 12.

Mean change in HbA1c (%) from baseline to Week 12 in experimental (n = 42; blue) and control (n = 42; orange) participants. Data are presented as mean (standard error). Between-group differences were assessed using a two-sided linear mixed-effects model adjusting for baseline HbA1c. The treatment effect was –0.40% (95% CI: –0.75 to –0.051; p = 0.025).